Beneficient (NASDAQ:BENF – Get Free Report) is expected to post its Q3 2026 results before the market opens on Thursday, February 12th. Analysts expect Beneficient to post earnings of ($0.92) per share for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2026 earning overview page for the latest details on the call scheduled for Thursday, February 12, 2026 at 4:00 PM ET.
Beneficient Price Performance
NASDAQ:BENF opened at $4.45 on Thursday. Beneficient has a fifty-two week low of $1.75 and a fifty-two week high of $12.48. The business has a 50 day moving average price of $5.58 and a 200-day moving average price of $4.53.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on BENF shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Beneficient in a research report on Monday, December 29th. Wall Street Zen upgraded shares of Beneficient to a “sell” rating in a report on Saturday, November 1st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
Further Reading
- Five stocks we like better than Beneficient
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
